ORGN · As filed with the SEC

Origin Materials cash flow statement, by quarter

The statement as Origin Materials presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS · USD thousands

USD thousandsQ1 2026
3 months ended Mar 31, 2026
Q4 2025†
3 months ended Dec 31, 2025
Q3 2025†
3 months ended Sep 30, 2025
Q2 2025†
3 months ended Jun 30, 2025
Cash flows from operating activities
Net loss(17,650)(194,128)†(16,382)†(12,747)†
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization1,1852,843†2,836†2,782†
Provision for credit losses4,620185†520†39†
Stock-based compensation1,0482,100†2,245†2,280†
Loss on reserves—0†——
Impairment of assets0178,816†210†0†
Realized (gain) loss on marketable securities(88)(30)†251†(54)†
Amortization of premium and discount of marketable securities, net(19)(47)†(43)†(11)†
Change in fair value of derivative00†(17)†(6)†
Change in fair value of common stock warrants liability(78)(351)†(163)†(1,107)†
Change in fair value of earnout liability00†0†0†
Change in fair value of convertible notes1,890———
Deferred tax provision0410†86†67†
Other non-cash expenses51168†394†133†
Changes in operating assets and liabilities:
Accounts receivable net and other receivables3,5802,655†2,039†1,637†
Inventory2(49)†53†178†
Prepaid expenses and other current assets1,322(403)†(423)†254†
Other long-term assets(965)53†77†23†
Accounts payable460(1,033)†(213)†(44)†
Accrued expenses(193)262†523†(665)†
Operating lease liabilities(74)(69)†(82)†(81)†
Other liabilities, current54(288)†(37)†37†
Other liabilities, long-term(12)(10)†(13)†(9)†
Net cash used in operating activities(4,867)(8,921)†(8,139)†(7,294)†
Cash flows from investing activities
Purchases of property, plant, and equipment(6,969)(9,109)†(5,388)†(8,716)†
Proceeds from land held for sale——0†—
Proceeds from sale of property, plant, and equipment36———
Purchases of marketable securities(128,153)(221,747)†(190,485)†(375,732)†
Sales of marketable securities132,792215,703†202,708†376,234†
Maturities of marketable securities2,5385,865†1,709†4,892†
Net cash (used in) provided by investing activities244(8,947)†8,544†(1,205)†
Cash flows from financing activities
Payment of notes payable and other liabilities—0†(1,730)†0†
Proceeds from Canadian Government Research and Development Program—1,678†0†0†
Proceeds from exercise of stock options—0†196†57†
Payment of notes payable short-term0———
Payment of convertible notes(8,640)———
Net cash used in financing activities(8,640)16,678†(1,534)†57†
Effects of foreign exchange rate changes on the balance of cash and cash equivalents held in foreign currencies(469)52†(105)†(98)†
Net decrease in cash and cash equivalents(13,732)(1,138)†(1,234)†(8,540)†
Cash and cash equivalents beginning of the period32,92334,06135,29543,835
Cash and cash equivalents end of the period19,19132,92334,06135,295
Supplemental disclosure of cash flow information
Purchases of fixed assets included in accounts payable and accrued expenses1,021(1,553)†(2,904)†4,046†
Purchases of property, plant, and equipment included in notes payable3,207———
Amount of shares issued for convertible notes1,241———
Cash paid during the period:
Income taxes payment—(26)†0†26†
Interest payment00†121†0†

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.